论文信息 - Monitoring asparaginase activity in middle-income countries. - 字舞流文

Monitoring asparaginase activity in middle-income countries.

J. A. Yunes | L. Daudt | I. Werlang | M. Goldani | M. Michalowski | P. Zenatti | C. Cabreira-Cagliari | A. Alegretti | C. Rechenmacher | Monique Cabral Hahn | A. Battistel | D. Cecconello | M. R. de Magalhães

[1] F. Gozzo,et al. Low Bioavailability and High Immunogenicity of a New Brand of E. colil-Asparaginase with Active Host Contaminating Proteins , 2018, EBioMedicine.

[2] M. Coleman,et al. Survival among children diagnosed with acute lymphoblastic leukemia in the United States, by race and age, 2001 to 2009: Findings from the CONCORD‐2 study , 2017, Cancer.

[3] H. Cavé,et al. Prolonged versus standard native E. coli asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951 , 2017, Haematologica.

[4] G. Hempel,et al. Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum. , 2002, Analytical biochemistry.

[5] H. Müller,et al. Use of L-asparaginase in childhood ALL. , 1998, Critical reviews in oncology/hematology.

[6] H. Jürgens,et al. Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. , 1996, European journal of cancer.